Application Detail
Status
OpenDescription of Medical Service
ImmunoHistoChemistry (IHC) test for evaluation of Programmed Cell Death Ligand 1 (PD-L1) expression to determine eligibility for treatment with pembrolizumabDescription of Medical Condition
unresectable mesotheliomaReason for Application
New MBS itemMedical Service Type
Co-dependent technologyPrevious Application Number
Not ApplicableAssociated Documentation
Application Form
Application form (PDF 247 KB)
Application form (Word 536 KB)
PICO Confirmation
PICO Confirmation (PDF 725 KB)PICO Confirmation (Word 210 KB)